Recruiting
Phase 3

Sponsor:

Karuna Therapeutics

Code:

NCT05511363

Conditions

Psychosis Associated With Alzheimer's Disease

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

KarXT

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-31. This information was provided to ClinicalTrials.gov by Karuna Therapeutics on 2025-03-11.